Acylcarnitine Profile, Quantitative, Plasma

TEST: 070228
Test number copied
CPT: 82017
Print Share

Expected Turnaround Time

3 - 7 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

Specimen Requirements

Specimen

Plasma, frozen

Volume

0.5 mL

Minimum Volume

0.1 mL (Note: This volume does not allow for repeat testing)

Container

Green-top (sodium heparin) tube

Collection

Transfer plasma to a plastic transport tube and freeze. To avoid delays in turnaround time when requesting multiple tests on frozen specimens, please submit separate frozen specimens for each test requested.

Storage Instructions

Frozen: 983 days (2.7 years)

Freeze/Thaw Cycle: Stable x3

Causes for Rejection

Specimen thawed or not frozen; gross hemolysis; specimen type other than frozen plasma

Test Details

Use

Used in the diagnosis and monitoring of inherited disorders of fatty acid oxidation and organic acidurias. May be used as a follow-up test to some abnormal newborn screen results.

Limitations

False-negative results can occur with acylcarnitine profiling, especially when the patient is carnitine deficient, is affected with a milder variant of a disorder, or when clinical condition or dietary supplementation causes secondary changes to the profile. Results of acylcarnitine profiling should be interpreted in the context of clinical presentation as well as other laboratory tests, which may include urine organic acid analysis and molecular testing.

This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).

Methodology

Flow injection/tandem mass spectrometry

References

Applied Biosystems. Chemoview Instructions. March 15, 2005.
Bennett M. Laboratory Medicine Practice Guidelines−Follow-up Testing for Metabolic Diseases Identified by Expanded Newborn Screening Using Tandem Mass Spectrometry. Washington DC: AACC Press;2009.
Rinaldo P, Cowan TM, Matern D. Acylcarnitine profile analysis. Genet Med. 2008 Feb; 10(2):151-156.18281923

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
070228 Acylcarnitine Profile, Plasma 43433-2 070081 C2 umol/L 30191-1
070228 Acylcarnitine Profile, Plasma 43433-2 070040 C3 umol/L 30551-6
070228 Acylcarnitine Profile, Plasma 43433-2 070041 C3-Dicarboxylic umol/L 55940-1
070228 Acylcarnitine Profile, Plasma 43433-2 070042 C4 umol/L 51413-3
070228 Acylcarnitine Profile, Plasma 43433-2 070043 C4-Hydroxy umol/L 39000-5
070228 Acylcarnitine Profile, Plasma 43433-2 070119 C4-Dicarboxylic umol/L 39010-4
070228 Acylcarnitine Profile, Plasma 43433-2 070044 C5 umol/L 30531-8
070228 Acylcarnitine Profile, Plasma 43433-2 070048 C5:1 umol/L 69573-4
070228 Acylcarnitine Profile, Plasma 43433-2 070049 C5-Hydroxy umol/L 51412-5
070228 Acylcarnitine Profile, Plasma 43433-2 070051 C5-Dicarboxylic umol/L 30349-5
070228 Acylcarnitine Profile, Plasma 43433-2 070057 C6 umol/L 30358-6
070228 Acylcarnitine Profile, Plasma 43433-2 070058 C8 umol/L 30540-9
070228 Acylcarnitine Profile, Plasma 43433-2 070059 C10 umol/L 30327-1
070228 Acylcarnitine Profile, Plasma 43433-2 070061 C10:1 umol/L 30328-9
070228 Acylcarnitine Profile, Plasma 43433-2 070062 C10:2 umol/L 53471-9
070228 Acylcarnitine Profile, Plasma 43433-2 070063 C12 umol/L 30331-3
070228 Acylcarnitine Profile, Plasma 43433-2 070064 C14 umol/L 30565-6
070228 Acylcarnitine Profile, Plasma 43433-2 070065 C14:1 umol/L 30566-4
070228 Acylcarnitine Profile, Plasma 43433-2 070066 C14:2 umol/L 30564-9
070228 Acylcarnitine Profile, Plasma 43433-2 070067 C14-Hydroxy umol/L 30238-0
070228 Acylcarnitine Profile, Plasma 43433-2 070068 C16 umol/L 30356-0
070228 Acylcarnitine Profile, Plasma 43433-2 070069 C16:1 umol/L 30357-8
070228 Acylcarnitine Profile, Plasma 43433-2 070070 C16:1-Hydroxy umol/L 30235-6
070228 Acylcarnitine Profile, Plasma 43433-2 070071 C16-Hydroxy umol/L 30234-9
070228 Acylcarnitine Profile, Plasma 43433-2 070072 C18 umol/L 30560-7
070228 Acylcarnitine Profile, Plasma 43433-2 070073 C18:1 umol/L 30542-5
070228 Acylcarnitine Profile, Plasma 43433-2 070074 C18:2 umol/L 30534-2
070228 Acylcarnitine Profile, Plasma 43433-2 070075 C18-Hydroxy umol/L 35656-8
070228 Acylcarnitine Profile, Plasma 43433-2 070076 C18:1-Hydroxy umol/L 30312-3
070228 Acylcarnitine Profile, Plasma 43433-2 070077 C18:2-Hydroxy umol/L 30237-2
070228 Acylcarnitine Profile, Plasma 43433-2 070082 Interpretation 46252-3
070228 Acylcarnitine Profile, Plasma 43433-2 070079 Director Review 72486-4
070228 Acylcarnitine Profile, Plasma 43433-2 070080 Methodology 49549-9
070228 Acylcarnitine Profile, Plasma 43433-2 700471 Disclaimer: N/A

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf